Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Urien

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Pharmaceutical Research|January 22, 1998
Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patientsH Russo, M P Dubboin, F Bressolle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1988
Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studiesJ Barre, S Urien, E Albengres, et al.
Pharmacological Research|March 8, 2000
Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain: a concentration-response study using forskolinD Morin, R Sapena, J P Tillement, et al.
Progress in Clinical and Biological Research|January 1, 1989
Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease statesS Urien, D Guez, A Thénot, et al.
Pharmaceutical Research|March 1, 1996
Nicanartine improves in vitro resistance of lipoproteins to oxidationE Dailly, S Urien, P Wülfroth, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 1999
A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizineS Urien, J P Tillement, B Ganem, et al.
Anticancer Research|July 1, 1996
Evaluation of two dose individualisation methods for carboplatinB Desoize, R Dufour, S Urien, et al.
Pharmacology|January 1, 1984
Multiple binding of bepridil in human bloodE Albengres, S Urien, J F Pognat, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarinS Urien, E Albengres, J L Pinquier, et al.
British Journal of Clinical Pharmacology|November 1, 1989
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseasesJ L Pinquier, S Urien, P Chaumet-Riffaud, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Pharmaceutical Research|January 22, 1998
Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patientsH Russo, M P Dubboin, F Bressolle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1988
Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studiesJ Barre, S Urien, E Albengres, et al.
Pharmacological Research|March 8, 2000
Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain: a concentration-response study using forskolinD Morin, R Sapena, J P Tillement, et al.
Progress in Clinical and Biological Research|January 1, 1989
Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease statesS Urien, D Guez, A Thénot, et al.
Pharmaceutical Research|March 1, 1996
Nicanartine improves in vitro resistance of lipoproteins to oxidationE Dailly, S Urien, P Wülfroth, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 1999
A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizineS Urien, J P Tillement, B Ganem, et al.
Anticancer Research|July 1, 1996
Evaluation of two dose individualisation methods for carboplatinB Desoize, R Dufour, S Urien, et al.
Pharmacology|January 1, 1984
Multiple binding of bepridil in human bloodE Albengres, S Urien, J F Pognat, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarinS Urien, E Albengres, J L Pinquier, et al.
British Journal of Clinical Pharmacology|November 1, 1989
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseasesJ L Pinquier, S Urien, P Chaumet-Riffaud, et al.
Pageof 13